Transgenic Mouse, ICSI & IVF Core
转基因小鼠,ICSI
基本信息
- 批准号:10225597
- 负责人:
- 金额:$ 21.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-13 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBasic ScienceBiogenesisBiomedical ResearchBusinessesCRISPR/Cas technologyCellular ImmunologyCenters of Research ExcellenceClinical ResearchCloningCollaborationsCommunicationCountryDNADerivation procedureDevelopmentDevelopmental BiologyDiseaseEconomicsEquipmentExtramural ActivitiesFacultyFundingGene DeliveryGene TransferGene Transfer TechniquesGenesGeneticGenetic TranscriptionGerm CellsGoalsGrowthHawaiiInstitutesInstitutionInterventionIntracytoplasmic Sperm InjectionsKnock-outLaboratoriesMaintenanceMarketingMicromanipulationMolecular ImmunologyMonitorMusNeeds AssessmentPhaseProceduresReproductive BiologyResearchResearch InstituteResearch PersonnelResearch SupportResource AllocationResourcesSchoolsScientistSeriesServicesSignal TransductionStructureTechniquesTechnologyTrainingTraining and EducationTransgenic AnimalsTransgenic MiceUniversitiesWorkbasebiomedical resourcecohesioneffectiveness evaluationembryo cultureexperiencegenome editingimprovedin vivoinnovationloss of functionnew technologynovelnovel therapeutic interventionoperationoutreachprogramsrecruitresearch and developmentsatisfactionservice deliverystem cellstool
项目摘要
PROJECT SUMMARY/ABSTRACT – Transgenic Mouse, ICSI and IVF Core
The ability to introduce foreign genes or to selectively knock out endogenous genes in animals is of
tremendous importance for basic and clinical research. In particular, with the advent of CRISPR/Cas
technology, unprecedented opportunities for in vivo gene modulations have arisen. As such, transgenesis is a
very powerful tool facilitating in vivo genome editing and transcription modulation, essential to dissect
transcriptional, signaling, and environmental influences on the genetic basis of diseases but also for the
development of novel therapeutic intervention strategies. Furthermore, mouse gamete manipulation, cloning
technology, stem cell derivation, and -culture are a series of techniques that are essential for many successful
research institutes in particular those with a focus on reproductive and developmental biology.
During Phase I, the University of Hawaii Transgenic Mouse, ICSI and IVF Core (TMII) at the Institute for
Biogenesis Research was established and made significant progress towards the goal of becoming
independently supported within fifteen years, accumulated a large array of equipment for micromanipulation of
mouse gametes and embryo culture and recruited experienced researchers to staff the Core laboratory.
Funding during Phase II strengthened and developed the COBRE Center into a state-of-the-art facility with an
outstanding track record in providing efficient and economic access to transgenic animals and related
technologies, including CRISPR technologies. The services were provided to COBRE faculty, University of
Hawaii researchers and scientists around the country. The Core continued the development of novel gene
delivery technology, including making significant progress on targeted gene insertion.
The objective of this Phase III COBRE application is to enhance and transform the Core into a self-
sustained resource entity. Besides expanding our Core services, we will continue to work on improving the
quality and delivery of these services and on enhancing and streamlining core operations. The Core will also
enhance its outreach and focus on education and training as principal conduits for the acquisition of new
customers at the University level. We will diversify our existing portfolio by coordinating and harmonizing our
Core resources and services with those of the Molecular and Cellular Immunology (MCI) Core. We also aim to
strengthen the core revenue base by increasing and diversify the contingent of investigators utilizing its many
offerings. Specifically, we will expand our outreach, improve marketing activities and explore opportunities for
collaborations with cores from other COBRE, INBRE and IDeA-CTR institutions.
项目总结/摘要-转基因小鼠、ICSI和IVF核心
在动物中引入外源基因或选择性敲除内源基因的能力是不可能的。
对基础和临床研究有着重要的意义。特别是,随着CRISPR/Cas的出现,
技术,体内基因调节的前所未有的机会已经出现。因此,转基因是一种
非常强大的工具,促进体内基因组编辑和转录调节,对于解剖
转录、信号和环境对疾病遗传基础的影响,
开发新的治疗干预策略。此外,小鼠配子操作,克隆
技术、干细胞衍生和培养是一系列技术,
研究机构,特别是那些侧重于生殖和发育生物学的研究机构。
在第一阶段,夏威夷大学的转基因小鼠,ICSI和IVF核心(TMII)在研究所,
生物生成研究所成立,并朝着成为
在十五年内独立支持,积累了大量的显微操作设备,
小鼠配子和胚胎培养,并招募有经验的研究人员为核心实验室工作。
第二阶段的资金加强并发展了COBRE中心,使其成为一个最先进的设施,
在提供高效和经济的转基因动物及相关产品方面有着出色的业绩记录,
包括CRISPR技术。这些服务提供给了哥伦比亚大学的COBRE教师,
全国各地的夏威夷研究人员和科学家。核心继续开发新基因
包括在靶向基因插入方面取得重大进展。
第三阶段COBRE应用的目标是增强和转变核心,使其成为一个自我管理的系统。
持续的资源实体。除了扩展核心服务外,我们会继续致力改善
这些服务的质量和交付以及加强和精简核心业务。核心也将
加强外联工作,注重教育和培训,将其作为获取新知识和技能的主要渠道,
大学层次的客户。我们将通过协调和统一我们的现有投资组合,
核心资源和服务与分子和细胞免疫学(MCI)核心。我们还旨在
通过利用其众多资源增加调查员队伍并使其多样化,加强核心收入基础
供品。具体而言,我们将扩大我们的外联活动,改善营销活动,并探索机会,
与其他COBRE、INBRE和IDEA-CTR机构的核心合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEFAN MOISYADI其他文献
STEFAN MOISYADI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEFAN MOISYADI', 18)}}的其他基金
An Identification System for Targeted Gene Addition to MLD Patient Derived iPSCs
用于向 MLD 患者衍生的 iPSC 添加靶向基因的鉴定系统
- 批准号:
8822754 - 财政年份:2014
- 资助金额:
$ 21.89万 - 项目类别:
Transposon Based Mammalian Transgenesis and Transfection
基于转座子的哺乳动物转基因和转染
- 批准号:
7645055 - 财政年份:2008
- 资助金额:
$ 21.89万 - 项目类别:
Transposon Based Mammalian Transgenesis and Transfection
基于转座子的哺乳动物转基因和转染
- 批准号:
8266439 - 财政年份:2008
- 资助金额:
$ 21.89万 - 项目类别:
Transposon Based Mammalian Transgenesis and Transfection
基于转座子的哺乳动物转基因和转染
- 批准号:
7848092 - 财政年份:2008
- 资助金额:
$ 21.89万 - 项目类别:
Transposon Based Mammalian Transgenesis and Transfection
基于转座子的哺乳动物转基因和转染
- 批准号:
8069618 - 财政年份:2008
- 资助金额:
$ 21.89万 - 项目类别:
Transposon Based Mammalian Transgenesis and Transfection
基于转座子的哺乳动物转基因和转染
- 批准号:
7526462 - 财政年份:2008
- 资助金额:
$ 21.89万 - 项目类别:
相似海外基金
HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
- 批准号:
2318404 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别:
Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
- 批准号:
10552484 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
- 批准号:
10576701 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
- 批准号:
480914 - 财政年份:2023
- 资助金额:
$ 21.89万 - 项目类别:
Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 21.89万 - 项目类别:
Australian Laureate Fellowships
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
- 批准号:
10517004 - 财政年份:2022
- 资助金额:
$ 21.89万 - 项目类别:
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
- 批准号:
22K02974 - 财政年份:2022
- 资助金额:
$ 21.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
- 批准号:
10431468 - 财政年份:2022
- 资助金额:
$ 21.89万 - 项目类别: